JPMorgan Adjusts XPENG-W Price Target to HK$118, Keeps Overweight Rating

Stock News
Jun 01

JPMorgan has updated its research report on XPENG-W (HKEX: 09868), revising its 2026 loss forecast to RMB 3.92 billion from a previous estimate of RMB 3.891 billion. The adjusted loss projection is set at RMB 3.47 billion, reflecting the company's first-quarter performance. Consequently, the bank has lowered its target price from HK$135 to HK$118.

The report notes that XPENG's Q1 results were largely in line with expectations. JPMorgan maintains a positive outlook on the company, anticipating an acceleration in sales growth starting from the second quarter. Additionally, expansion in overseas markets and developments related to artificial intelligence are expected to support a long-term potential revaluation of the stock. The firm reaffirms its "Overweight" rating.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10